| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Microbiology and Infectious Diseases, Faculty of Medicine, University of Calgary, Alberta, Canada;
Department of Pathology and Laboratory Medicine, University of British Columbia and British Columbia’s Children’s Hospital, Vancouver, British Columbia, Canada; and
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada
Activated T cells and their naive precursors display different functional avidities for peptide/MHC, but are thought to have identical antigenic repertoires. We show that, following activation with a cognate mimotope (NRP), diabetogenic CD8+ T cells expressing a single TCR (8.3) respond vigorously to numerous peptide analogs of NRP that were unable to elicit any responses from naive 8.3-CD8+ T cells, even at high concentrations. The NRP-reactive, in vivo activated CD8+ cells arising in pancreatic islets of nonobese diabetic mice are similarly promiscuous for peptide/MHC, and paradoxically this promiscuity expands as the aviditiy of the T cell population for NRP/MHC increases with age. Thus, activation and avidity maturation of T lymphocyte populations can lead to dramatic expansions in the range of peptides that elicit functional T cell responses.
This article has been cited by other articles:
|
|
 |
|
  K. L. Graham, N. Sanders, Y. Tan, J. Allison, T. W. H. Kay, and B. S. Coulson Rotavirus Infection Accelerates Type 1 Diabetes in Mice with Established Insulitis J. Virol., July 1, 2008; 82(13): 6139 - 6149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tailor, S. Tsai, A. Shameli, P. Serra, J. Wang, S. Robbins, M. Nagata, A. L. Szymczak-Workman, D. A. A. Vignali, and P. Santamaria The Proline-Rich Sequence of CD3{epsilon} as an Amplifier of Low-Avidity TCR Signaling J. Immunol., July 1, 2008; 181(1): 243 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Desrosiers, K. M. Cembrola, M. J. Fakir, L. A. Stephens, F. M. Jama, A. Shameli, W. Z. Mehal, P. Santamaria, and Y. Shi Adenosine Deamination Sustains Dendritic Cell Activation in Inflammation J. Immunol., August 1, 2007; 179(3): 1884 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kao, M. A. Daniels, and S. C. Jameson Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation Int. Immunol., December 1, 2005; 17(12): 1607 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lieberman, T. Takaki, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo Individual Nonobese Diabetic Mice Exhibit Unique Patterns of CD8+ T Cell Reactivity to Three Islet Antigens, Including the Newly Identified Widely Expressed Dystrophia Myotonica Kinase J. Immunol., December 1, 2004; 173(11): 6727 - 6734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Reijonen, R. Mallone, A.-K. Heninger, E. M. Laughlin, S. A. Kochik, B. Falk, W. W. Kwok, C. Greenbaum, and G. T. Nepom GAD65-Specific CD4+ T-Cells with High Antigen Avidity Are Prevalent in Peripheral Blood of Patients With Type 1 Diabetes Diabetes, August 1, 2004; 53(8): 1987 - 1994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moore, J. Grimm, B. Han, and P. Santamaria Tracking the Recruitment of Diabetogenic CD8+ T-Cells to the Pancreas in Real Time Diabetes, June 1, 2004; 53(6): 1459 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Serreze, T. M. Holl, M. P. Marron, R. T. Graser, E. A. Johnson, C. Choisy-Rossi, R. M. Slattery, S. M. Lieberman, and T. P. DiLorenzo MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice J. Immunol., January 15, 2004; 172(2): 871 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yamanouchi, J. Verdaguer, B. Han, A. Amrani, P. Serra, and P. Santamaria Cross-Priming of Diabetogenic T Cells Dissociated from CTL-Induced Shedding of {beta} Cell Autoantigens J. Immunol., December 15, 2003; 171(12): 6900 - 6909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. SANTAMARIA Kinetic Evolution of a Diabetogenic CD8+ T Cell Response Ann. N.Y. Acad. Sci., November 1, 2003; 1005(1): 88 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Hutton and G. S. Eisenbarth A pancreatic {beta}-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes PNAS, July 22, 2003; 100(15): 8626 - 8628. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lieberman, A. M. Evans, B. Han, T. Takaki, Y. Vinnitskaya, J. A. Caldwell, D. V. Serreze, J. Shabanowitz, D. F. Hunt, S. G. Nathenson, et al. Identification of the {beta} cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes PNAS, July 8, 2003; 100(14): 8384 - 8388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kimachi, K. Sugie, and H. M. Grey Effector T cells have a lower ligand affinity threshold for activation than naive T cells Int. Immunol., July 1, 2003; 15(7): 885 - 892. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
